Akebia Therapeutics, Inc.

AKBA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$51,870$42,925$90,466$149,800
Short-Term Investments$0$0$0$0
Receivables$34,368$39,290$40,284$51,581
Inventory$16,243$15,691$21,568$36,628
Other Curr. Assets$11,350$20,243$32,864$33,140
Total Curr. Assets$113,831$118,149$185,182$271,149
Property Plant & Equip (Net)$10,418$16,045$34,372$40,606
Goodwill$59,044$59,044$59,044$59,044
Intangibles$0$36,042$72,084$108,127
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$37,377$12,423$5,372$50,421
Total NC Assets$106,839$123,554$170,872$258,198
Other Assets$0$0$0$0
Total Assets$220,670$241,703$356,054$529,347
Liabilities
Payables$15,180$14,635$18,021$33,588
Short-Term Debt$9,713$24,039$36,744$102,345
Tax Payable$0$0$0$0
Deferred Revenue$0$0$3,738$20,906
Other Curr. Liab.$56,021$61,196$71,033$104,212
Total Curr. Liab.$80,914$99,870$129,536$261,051
LT Debt$179,016$80,143$63,039$33,703
Deferred Rev, NC$0$43,296$43,296$21,474
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$9,925$48,978$114,953$139,111
Total NC Liab.$188,941$172,417$221,288$194,288
Other Liabilities$0$0$0$0
Cap. Leases$8,947$13,438$33,705$38,505
Total Liabilities$269,855$272,287$350,824$455,339
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$2$1
Retained Earnings-$1,678,360-$1,608,950-$1,557,025-$1,462,799
AOCI$6$6$6$6
Other Equity$1,629,167$1,578,358$1,562,247$1,536,800
Total Equity-$49,185-$30,584$5,230$74,008
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$220,670$241,703$356,054$529,347
Net Debt$136,859$61,257$9,317-$13,752